LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 35

Search options

  1. Article ; Online: Polycystic ovary syndrome and assisted reproduction: splitters versus lumpers.

    Garzon, S / Laganà, A S

    BJOG : an international journal of obstetrics and gynaecology

    2020  Volume 128, Issue 6, Page(s) 1011

    MeSH term(s) Female ; Humans ; Hyperandrogenism ; Polycystic Ovary Syndrome ; Pregnancy ; Reproduction ; Retrospective Studies
    Keywords covid19
    Language English
    Publishing date 2020-11-12
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 2000931-8
    ISSN 1471-0528 ; 0306-5456 ; 1470-0328
    ISSN (online) 1471-0528
    ISSN 0306-5456 ; 1470-0328
    DOI 10.1111/1471-0528.16577
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Can the endometrioma be an obstacle to complete oocyte retrieval in IVF cycles? A retrospective study.

    Baldini, G M / Laganà, A S / Mastrorocco, A / Malvasi, A / Baldini, D / Ferri, D / Sciorio, R / Trojano, G

    European review for medical and pharmacological sciences

    2024  Volume 28, Issue 7, Page(s) 2827–2836

    Abstract: Objective: The study aimed to evaluate the utility and safety of ancillary maneuvers during oocyte retrieval for patients with endometrioma that makes ovum pick-up hard due to poor ovarian surgical accessibility.: Patients and methods: Cases of 251 ... ...

    Abstract Objective: The study aimed to evaluate the utility and safety of ancillary maneuvers during oocyte retrieval for patients with endometrioma that makes ovum pick-up hard due to poor ovarian surgical accessibility.
    Patients and methods: Cases of 251 women with ovarian endometriomas undergoing in vitro fertilization (IVF) in our infertility unit were retrospectively analyzed to evaluate the clinical IVF cycle outcomes after oocyte retrieval. Controls (n = 251) were age-matched women without endometriomas who underwent an uncomplicated oocyte retrieval.
    Results: No statistically significant differences were observed between groups except for the number of oocytes retrieved, which was higher in the control group than in the group of women with endometrioma. On the contrary, there were no differences between the experimental groups in the fertilization rate and number of embryos, and neither were there in the pregnancy and live birth rate. Moreover, the surgical complications were infrequent and similar between the two analyzed groups. Accidental or voluntary endometrioma punctures were not accompanied by increases in the risk of a pelvic infection.
    Conclusions: In conclusion, patients with endometrioma can undergo high-performance oocyte recovery procedures thanks to safe accessory maneuvers during the ovum pick-up.
    MeSH term(s) Pregnancy ; Humans ; Female ; Endometriosis/surgery ; Endometriosis/complications ; Retrospective Studies ; Oocyte Retrieval ; Fertilization in Vitro ; Infertility ; Pregnancy Rate
    Language English
    Publishing date 2024-04-19
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 605550-3
    ISSN 2284-0729 ; 1128-3602 ; 0392-291X
    ISSN (online) 2284-0729
    ISSN 1128-3602 ; 0392-291X
    DOI 10.26355/eurrev_202404_35911
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: D-Chiro-Inositol's action as aromatase inhibitor: rationale and potential clinical targets.

    Laganà, A S / Unfer, V

    European review for medical and pharmacological sciences

    2019  Volume 23, Issue 24, Page(s) 10575–10576

    MeSH term(s) Aromatase/genetics ; Aromatase/metabolism ; Aromatase Inhibitors/chemistry ; Aromatase Inhibitors/pharmacology ; Female ; Humans ; Inositol/chemistry ; Inositol/pharmacology ; Polycystic Ovary Syndrome/drug therapy ; Polycystic Ovary Syndrome/enzymology ; Stereoisomerism
    Chemical Substances Aromatase Inhibitors ; Inositol (4L6452S749) ; Aromatase (EC 1.14.14.1)
    Language English
    Publishing date 2019-12-19
    Publishing country Italy
    Document type Letter
    ZDB-ID 605550-3
    ISSN 2284-0729 ; 1128-3602 ; 0392-291X
    ISSN (online) 2284-0729
    ISSN 1128-3602 ; 0392-291X
    DOI 10.26355/eurrev_201912_19752
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Effects of herbal compounds on various aspects of endometriosis treatment: a systematic review.

    Momenimovahed, Z / Salehiniya, H / Allahqoli, L / Laganà, A S / Mazidimoradi, A / Moawad, G / Gitas, G / Alkatout, I

    European review for medical and pharmacological sciences

    2024  Volume 28, Issue 9, Page(s) 3375–3383

    Abstract: Objective: Endometriosis means the presence of tissue similar to normal endometrium outside the uterus. Although surgical, hormonal, and analgesic treatment relieves symptoms and improves fertility, it is associated with side effects and a high ... ...

    Abstract Objective: Endometriosis means the presence of tissue similar to normal endometrium outside the uterus. Although surgical, hormonal, and analgesic treatment relieves symptoms and improves fertility, it is associated with side effects and a high recurrence rate. Alternative medicines like medicinal plants have been used for the treatment of chronic diseases. Given the global importance of endometriosis as a chronic disease affecting over 15% of all women in their fertile period, this systematic review aimed to give a comprehensive view of research on medicinal plants.
    Materials and methods: Comprehensive searches were performed on three databases, including PubMed/MEDLINE, Web of Science Core Collection (Indexes = SCI-EXPANDED, SSCI, A, and HCI Timespan), and Scopus, to identify papers published until June 2023. Keywords, such as "Endometriosis" and "Herbal Medicine", were used to search. A manual search of valid journals followed by a manual search of the references of the retrieved full-text articles was performed. All retrieved articles were imported into a database into Endnote X9. Articles that did not meet the inclusion criteria were excluded from the study, and the full texts of all the articles that met the inclusion criteria were assessed. Studies that evaluated the effects of herbal compounds on various aspects of endometriosis treatment were included in the review.
    Results: In total, 11 studies were included in the present study. The evidence showed that in addition to safety, drugs available alongside treatments could play an effective role in improving the symptoms associated with endometriosis. In this study, the positive results of using Chinese treatments were reported in aspects such as fertility rate, pain, endometriosis recurrence rate, quality of life, sexual function, CA-125 level, and menopause symptoms.
    Conclusions: A wide range of preclinical and clinical studies evaluated the effectiveness and safety of medicinal plants in the treatment of endometriosis symptoms. Thus, alternative treatments for endometriosis with no or low side effects should be included in the holistic treatment of endometriosis upfront. However, there is still a need for well-designed trials to investigate standard interventions and specific and safe doses of herbal medicines.
    MeSH term(s) Endometriosis/drug therapy ; Humans ; Female ; Plants, Medicinal/chemistry ; Phytotherapy ; Plant Preparations/therapeutic use
    Language English
    Publishing date 2024-05-20
    Publishing country Italy
    Document type Journal Article ; Systematic Review
    ZDB-ID 605550-3
    ISSN 2284-0729 ; 1128-3602 ; 0392-291X
    ISSN (online) 2284-0729
    ISSN 1128-3602 ; 0392-291X
    DOI 10.26355/eurrev_202405_36182
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Effect of the COVID-19 pandemic on oncology screenings: it is time to change course.

    Scioscia, M / Noventa, M / Palomba, S / Laganà, A S

    BJOG : an international journal of obstetrics and gynaecology

    2021  Volume 128, Issue 13, Page(s) 2213–2214

    MeSH term(s) Adenoma/diagnosis ; Adenoma/pathology ; Breast Neoplasms/diagnosis ; Breast Neoplasms/pathology ; COVID-19 ; Carcinoma/diagnosis ; Carcinoma/pathology ; Colorectal Neoplasms/diagnosis ; Colorectal Neoplasms/pathology ; Early Detection of Cancer/trends ; Female ; Humans ; Italy ; Missed Diagnosis/trends ; SARS-CoV-2 ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/pathology
    Language English
    Publishing date 2021-08-17
    Publishing country England
    Document type Letter
    ZDB-ID 2000931-8
    ISSN 1471-0528 ; 0306-5456 ; 1470-0328
    ISSN (online) 1471-0528
    ISSN 0306-5456 ; 1470-0328
    DOI 10.1111/1471-0528.16857
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Does Alpha-lipoic acid improve effects on polycystic ovary syndrome?

    Laganà, A S / Monti, N / Fedeli, V / Gullo, G / Bizzarri, M

    European review for medical and pharmacological sciences

    2022  Volume 26, Issue 4, Page(s) 1241–1247

    Abstract: Alpha-lipoic acid (ALA) plays a key role in many physiological processes, exerting anti-inflammatory, immunomodulatory, antioxidant, detoxifying, and insulin sensitizing activities. Since ALA improves insulin resistance (IR), it has been suggested that ... ...

    Abstract Alpha-lipoic acid (ALA) plays a key role in many physiological processes, exerting anti-inflammatory, immunomodulatory, antioxidant, detoxifying, and insulin sensitizing activities. Since ALA improves insulin resistance (IR), it has been suggested that ALA could be beneficial it in the treatment of PCOS. The natural polyol myo-Inositol (myo-Ins) and its isomers (D-Chiro-Inositol, D-Chiro-Ins) has proven to improve PCOS features and clinical outcome, according to a compelling body of available studies. Few studies have proposed to strengthen the inositol effect by associating ALA. ALA does not seem to influence significantly reproductive hormones, while its beneficial effects are presumably restricted to the metabolic features of insulin resistant PCOS women. Therefore, ALA usefulness in improving inositol activity still awaits convincingly confirmation.  Experimental studies as well as proper randomized clinical trials, should be specifically tailored to assess this hypothesis. In absence of reliable evidence, ALA should not be recommended in the routinary clinical management of PCOS, even if associated to myo-Ins.
    MeSH term(s) Female ; Humans ; Inositol/therapeutic use ; Insulin/metabolism ; Insulin Resistance ; Polycystic Ovary Syndrome/drug therapy ; Polycystic Ovary Syndrome/metabolism ; Thioctic Acid/therapeutic use
    Chemical Substances Insulin ; Inositol (4L6452S749) ; Thioctic Acid (73Y7P0K73Y)
    Language English
    Publishing date 2022-02-18
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 605550-3
    ISSN 2284-0729 ; 1128-3602 ; 0392-291X
    ISSN (online) 2284-0729
    ISSN 1128-3602 ; 0392-291X
    DOI 10.26355/eurrev_202202_28116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?

    Bizzarri, M / Laganà, A S / Aragona, D / Unfer, V

    European review for medical and pharmacological sciences

    2020  Volume 24, Issue 6, Page(s) 3426–3432

    Abstract: The outbreak of Sars-CoV-2 (COVID-19) poses serious challenges to people's health worldwide. The management of the disease is mostly supportive, and respiratory failure from acute respiratory distress syndrome is the leading cause of death in a ... ...

    Abstract The outbreak of Sars-CoV-2 (COVID-19) poses serious challenges to people's health worldwide. The management of the disease is mostly supportive, and respiratory failure from acute respiratory distress syndrome is the leading cause of death in a significant proportion of affected patients. Preliminary data point out that dramatic increase in IL-6 and subsequent cytokine release syndrome may account for the development of fatal interstitial pneumonia. Inhibition of IL-6 by blocking its specific receptor with monoclonal antibodies has been advocated as a promising attempt. Here we assess the potential utility of myo-Inositol, a polyol already in use for treating the newborn Respiratory Distress Syndrome, in downregulating the inflammatory response upon Sars-CoV-2 infection. Myo-Inositol proved to reduce IL-6 levels in a number of conditions and to mitigate the inflammatory cascade, while being devoid of any significant side effects. It is tempting to speculate that inositol could be beneficial in managing the most dreadful effects of Sars-CoV-2 infection.
    MeSH term(s) Betacoronavirus/drug effects ; Coronavirus Infections/complications ; Coronavirus Infections/drug therapy ; Coronavirus Infections/physiopathology ; Cytokine Release Syndrome/etiology ; Down-Regulation ; Humans ; Inositol/therapeutic use ; Interleukin-6/metabolism ; Lung Neoplasms/metabolism ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/physiopathology
    Chemical Substances IL6 protein, human ; Interleukin-6 ; Inositol (4L6452S749)
    Keywords covid19
    Language English
    Publishing date 2020-04-08
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 605550-3
    ISSN 2284-0729 ; 1128-3602 ; 0392-291X
    ISSN (online) 2284-0729
    ISSN 1128-3602 ; 0392-291X
    DOI 10.26355/eurrev_202003_20715
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients.

    Hernandez Marin, I / Picconi, O / Laganà, A S / Costabile, L / Unfer, V

    European review for medical and pharmacological sciences

    2021  Volume 25, Issue 8, Page(s) 3316–3324

    Abstract: Objective: This open-label non-randomized clinical study aimed at evaluating the effects of myo-inositol plus alpha-lactalbumin in two groups of PCOS women, treated in Mexico and Italy. Alpha-lactalbumin was used being effective in increasing myo- ... ...

    Abstract Objective: This open-label non-randomized clinical study aimed at evaluating the effects of myo-inositol plus alpha-lactalbumin in two groups of PCOS women, treated in Mexico and Italy. Alpha-lactalbumin was used being effective in increasing myo-inositol intestinal absorption. This effect is very useful in greatly reducing the therapeutic failure of myo-inositol in some patients (inositol resistant subjects).
    Patients and methods: The study involved 34 normal weight or overweight patients (14 in Mexico and 20 in Italy), aged 18 to 40 years, with anovulation and infertility > 1 year and insulin resistance diagnosed by HOMA-Index. Patients were administered orally with 2 g myo-inositol, 50 mg alpha-lactalbumin, and 200 µg of folic acid twice a day for 6 months. Controls were the same patients at t0 (baseline). The primary outcome was HOMA-index decrease after 3 and 6 months of treatment. Other parameters monitored were BMI, progesterone, LH, FSH, total testosterone, free testosterone, androstenedione, total cholesterol, HDL, LDL, triglycerides.
    Results: Recovery was general, and its relevance was higher when the starting point was further away from the normal range. The most important results were obtained with insulin, HOMA-index, LH, and androstenedione. No significant adverse effects were detected in both groups of patients.
    Conclusions: This clinical trial demonstrated for the first time that myo-inositol and alpha-lactalbumin improve important parameters in PCOS patients characterized by different metabolic profiles.
    MeSH term(s) Adolescent ; Adult ; Female ; Humans ; Inositol/therapeutic use ; Italy ; Lactalbumin/therapeutic use ; Mexico ; Overweight/drug therapy ; Polycystic Ovary Syndrome/drug therapy ; Young Adult
    Chemical Substances Inositol (4L6452S749) ; Lactalbumin (9013-90-5)
    Language English
    Publishing date 2021-03-23
    Publishing country Italy
    Document type Clinical Trial ; Journal Article ; Multicenter Study
    ZDB-ID 605550-3
    ISSN 2284-0729 ; 1128-3602 ; 0392-291X
    ISSN (online) 2284-0729
    ISSN 1128-3602 ; 0392-291X
    DOI 10.26355/eurrev_202104_25743
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: T-shaped uterus: stepping up the ladder of evidence.

    Carugno, J / Laganà, A S / Haimovich, S / Pacheco, L Alonso / Sardo, A Di Spiezio

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

    2021  Volume 57, Issue 3, Page(s) 509–510

    MeSH term(s) Female ; Humans ; Urogenital Abnormalities ; Uterus/diagnostic imaging
    Language English
    Publishing date 2021-03-01
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 1073183-0
    ISSN 1469-0705 ; 0960-7692
    ISSN (online) 1469-0705
    ISSN 0960-7692
    DOI 10.1002/uog.23603
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?

    Bizzarri, M / Laganà, A S / Aragona, D / Unfer, V

    Eur Rev Med Pharmacol Sci

    Abstract: The outbreak of Sars-CoV-2 (COVID-19) poses serious challenges to people's health worldwide. The management of the disease is mostly supportive, and respiratory failure from acute respiratory distress syndrome is the leading cause of death in a ... ...

    Abstract The outbreak of Sars-CoV-2 (COVID-19) poses serious challenges to people's health worldwide. The management of the disease is mostly supportive, and respiratory failure from acute respiratory distress syndrome is the leading cause of death in a significant proportion of affected patients. Preliminary data point out that dramatic increase in IL-6 and subsequent cytokine release syndrome may account for the development of fatal interstitial pneumonia. Inhibition of IL-6 by blocking its specific receptor with monoclonal antibodies has been advocated as a promising attempt. Here we assess the potential utility of myo-Inositol, a polyol already in use for treating the newborn Respiratory Distress Syndrome, in downregulating the inflammatory response upon Sars-CoV-2 infection. Myo-Inositol proved to reduce IL-6 levels in a number of conditions and to mitigate the inflammatory cascade, while being devoid of any significant side effects. It is tempting to speculate that inositol could be beneficial in managing the most dreadful effects of Sars-CoV-2 infection.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #51429
    Database COVID19

    Kategorien

To top